Ask The Board

  1. What Factors Are Most Important To Consider When Collaborating Externally On A Combination Drug Clinical Trial? 12/1/2022

    See the answer from Martin Lehr, CEO at Context Therapeutics.

  2. What Impact Do You Think The Inflation Reduction Act Will Have On The Biopharma Industry Over The Next Five Years? 12/1/2022

    See the answer from Ron Cohen, president and CEO at Acorda Therapeutics.

  3. How Can Leaders Keep Employees Motivated And Focused On Long-Term Objectives In The Context Of Difficult Market Conditions And Short-Term Belt Tightening? 11/1/2022

    See the answer from Paula Ragan, cofounder, president, and CEO of X4 Pharmaceuticals.

  4. What Do Corporate Diversity, Equity, And Inclusion (DE&I) Programs Most Often Get Wrong? How Could They Be Improved? 11/1/2022

    See the answer from Paul Hastings, president and CEO of Nkarta Therapeutics and chair of the board of directors at BIO.

  5. How Can Company Leaders Maintain Commercial Momentum With Marketed Products Without Losing Focus On New Drug Development Programs? 10/3/2022

    See the answer from Tim Wright, CEO of MiMedx.

  6. How Can Novel Data Registries Inform The Development Of New Medicines, Or Improve Patient Care? 10/3/2022

    See the answer from Lisa Conte, founder, president, and CEO of Jaguar Health.

  7. Your New Book Is Pharma And Profits: Balancing Innovation, Medicine And Drug Pricing. What Is Most Often Overlooked In Political Discussions About Drug Prices? 10/3/2022

    See the answer from John Lamattina, a senior partner at PureTech Health.

  8. How Can Biopharma Companies Effectively Maintain Quality And Manage Risk While Rapidly Scaling Up Operations? 9/1/2022

    See the answer from Jason Urban, executive director, R&D quality risk management, governance, and analytics at Gilead Sciences.

  9. What Can Preclinical Or Early-Stage Biotech Companies Do In The Current Market To Better Access Needed Capital And Resources? 9/1/2022

    See the answer from Dennis Purcell, the founder and senior advisor at Aisling Capital.

  10. What Can Small Biotech Companies Do To Prepare For Worsening Macroeconomic Conditions? 9/1/2022

    See the answer from Leslie Williams, cofounder, president, and CEO of hC Bioscience.